文献速递血栓与止血

血小板TGF-β1缺陷减轻肝损伤小鼠模型的肝纤维化

Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury.
PubMed 文献 · Blood Adv · 2018-01-01

在四氯化碳诱导的急性肝损伤和慢性纤维化小鼠模型中,血小板TGF-β1缺陷小鼠(PF4CreTgfb1f/f)与野生型小鼠肝损伤程度相当,但PF4CreTgfb1f/f小鼠肝纤维化程度低于对照小鼠;野生型小鼠中观察到血小板活化、TGF-β1水平短暂升高及Smad2磷酸化信号,而PF4CreTgfb1f/f小鼠中未观察到这些变化,提示血小板释放的TGF-β1部分通过启动肝星状细胞促纤维化信号和胶原合成参与肝纤维化。

要点

  • 血小板TGF-β1缺陷小鼠肝损伤程度与野生型相当,但肝纤维化程度更轻。
  • 野生型小鼠急性肝损伤时可见血小板活化及TGF-β1和Smad2磷酸化信号短暂升高,PF4CreTgfb1f/f小鼠未见。
  • 作者认为血小板TGF-β1部分通过启动肝星状细胞促纤维化信号和胶原合成参与肝纤维化。

核心结论

  • 血小板TGF-β1部分参与肝纤维化,最可能通过启动肝星状细胞促纤维化信号和胶原合成发挥作用。
  • 作者提出需进一步研究在急性肝损伤期间阻断血小板和TGF-β1活化是否能预防肝纤维化。

研究设计与样本

  • 研究为小鼠模型实验,比较野生型(WT)小鼠与血小板TGF-β1缺陷(PF4CreTgfb1f/f)小鼠,使用四氯化碳(CCl4)诱导急性肝损伤和慢性纤维化。

主要发现

  • CCl4诱导的肝损伤在WT和PF4CreTgfb1f/f小鼠中程度相当,依据细胞色素P450(Cyp2e1)表达缺失评估,于CCl4攻击后6小时观察到、3天达峰。
  • PF4CreTgfb1f/f小鼠肝纤维化程度低于对照小鼠。
  • 急性肝损伤6小时观察到活化血小板;与对照小鼠相比,短暂血小板减少的WT小鼠发生纤维化的程度部分减轻(P = .01),提示血小板活化与纤维化之间存在关联。
  • CCl4攻击后6小时和3天,WT小鼠分别观察到TGF-β1水平和Smad2磷酸化信号短暂升高,而PF4CreTgfb1f/f小鼠未观察到,提示初始损伤期间升高的TGF-β1来源于血小板释放的TGF-β1。
  • 产胶原的肝星状细胞和肌成纤维细胞数量在WT vs PF4CreTgfb1f/f小鼠中分别于3天和36天更高,提示血小板TGF-β1可能刺激肝星状细胞向肌成纤维细胞转分化。

关键数值与推荐

  • 短暂血小板减少的WT小鼠与对照小鼠相比,纤维化发生部分减轻(P = .01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者提出需进一步研究评估在急性肝损伤期间阻断血小板和TGF-β1活化是否能预防肝纤维化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transforming growth factor-β1 (TGF-β1) signaling in hepatic stellate cells (HSCs) plays a primary role in liver fibrosis, but the source of TGF-β1 is unclear. Because platelets are rich in TGF-β1, we examined the role of platelet TGF-β1 in liver fibrosis by challenging wild-type (WT) mice and mice deficient in platelet TGF-β1 (PF4CreTgfb1f/f) with carbon tetrachloride (CCl4), an inducer of acute hepatic injury and chronic fibrosis. CCl4 elicited equivalent hepatic injury in WT and PF4CreTgfb1f/f mice based on loss of cytochrome P450 (Cyp2e1) expression, observed at 6 hours and peaking at 3 days after CCl4 challenge; PF4CreTgfb1f/f mice exhibited less liver fibrosis than control mice. Activated platelets were observed during acute liver injury (6 hours), and WT mice with transient platelet depletion (thrombocytopenia) were partially protected from developing fibrosis compared with control mice (P = .01), suggesting an association between platelet activation and fibrosis. Transient increases in TGF-β1 levels and Smad2 phosphorylation signaling were observed 6 hours and 3 days, respectively, after CCl4 challenge in WT, but not PF4CreTgfb1f/f , mice, suggesting that increased TGF-β1 levels originated from platelet-released TGF-β1 during the initial injury. Numbers of collagen-producing HSCs and myofibroblasts were higher at 3 days and 36 days, respectively, in WT vs PF4CreTgfb1f/f mice, suggesting that platelet TGF-β1 may have stimulated HSC transdifferentiation into myofibroblasts. Thus, platelet TGF-β1 partially contributes to liver fibrosis, most likely by initiating profibrotic signaling in HSCs and collagen synthesis. Further studies are required to evaluate whether blocking platelet and TGF-β1 activation during acute liver injury prevents liver fibrosis.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Ghafoory S, Varshney R, Robison T, et al. Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury. Blood Adv. 2018. PMID: 29490978. doi:10.1182/bloodadvances.2017010868

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。